Rosiglitazone disrupts endosteal bone formation during distraction osteogenesis by local adipocytic infiltration.
Liu L, Aronson J, Lecka-Czernik B. Rosiglitazone disrupts endosteal bone formation during distraction osteogenesis by local adipocytic infiltration. Bone. 2013 Jan; 52(1):247-58.